Raleigh Capital Management Inc. Grows Position in iShares U.S. Pharmaceuticals ETF $IHE

Raleigh Capital Management Inc. increased its holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 865,800.0% in the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 8,659 shares of the company’s stock after buying an additional 8,658 shares during the quarter. Raleigh Capital Management Inc.’s holdings in iShares U.S. Pharmaceuticals ETF were worth $751,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Heritage Oak Wealth Advisors LLC bought a new position in iShares U.S. Pharmaceuticals ETF during the 1st quarter valued at about $530,000. Root Financial Partners LLC grew its stake in shares of iShares U.S. Pharmaceuticals ETF by 36.5% in the first quarter. Root Financial Partners LLC now owns 696 shares of the company’s stock worth $60,000 after acquiring an additional 186 shares during the period. American Institute for Advanced Investment Management LLP bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the first quarter worth approximately $464,000. Cornerstone Wealth Group LLC raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 13.7% during the first quarter. Cornerstone Wealth Group LLC now owns 2,847 shares of the company’s stock valued at $246,000 after purchasing an additional 342 shares during the last quarter. Finally, AdvisorNet Financial Inc raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 2.5% during the first quarter. AdvisorNet Financial Inc now owns 40,993 shares of the company’s stock valued at $3,553,000 after purchasing an additional 983 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Performance

Shares of IHE stock opened at $100.96 on Friday. iShares U.S. Pharmaceuticals ETF has a 12-month low of $64.94 and a 12-month high of $100.96. The firm’s 50 day moving average is $91.69 and its 200 day moving average is $88.76. The stock has a market capitalization of $1.17 billion, a P/E ratio of 17.75 and a beta of 0.49.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.